Abbott’s Takedown Shakedown – an update
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
Abbott
Abbott’s Takedown Shakedown. No Libre no more
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
Dexcom’s Stelo by numbers. Could a 15 day G7 be imminent?
With performance numbers on the new 15-day, prescription free, Stelo sensor from Dexcom looking very similar to those from the G7, could Dexcom be contemplating the announcement of an uldated 15-day iCGM at EASD in Madrid?
Waving the white flag? Medtronic partners with Abbott for CGM.
Breaking news in the world of Diabetes tech today saw Medtronic and Abbott share news of a partnership to provide Abbott CGM technology to Medtronic […]
Welcome to the Wild, Wild West: the CGM head-to-head study
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
Lies, damned lies and statistics. The art of the CGM accuracy study.
How do you compare two different CGMs? It seems like a stupid question. It’s obvious. You look at the Mean Absolute Relative Difference (MARD) of […]
Abbott Freestyle Libre 3 – here already?
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
High temperatures, extreme conditions and glucose sensors… an n=1 observation
As many of us do going in to the new year, I made a decision to be more active, eat more healthily, etc. The usual […]
Death or profit: Flash, CGM and patient-centricity
As many people with T1D in the UK will know, there has been an ongoing dialogue between NHS England and the DVLA with respect to […]
Happy World Diabetes Day from NHS England – #FreestyleLibre for all?
World Diabetes Day 2018. The day that NHS England had enough. The announcement If you hadn’t seen it, NHS England issued a press release early […]